65

Prevention of bone metastases in patients with high-risk nonmetastatic prostate cancer treated with zoledronic acid: Efficacy and safety results of the zometa European study (ZEUS).

Wirth M, Tammela T, Cicalese V, Veiga FG, Delaere K, Miller K, TubaroA, Schulze M, Debruyne F, Huland H, Patel A, Lecouvet F, Caris C, Witjes W.

Eur Urol. 2015

Posaproca/SPCG

Abstract

64

Radical prostatectomy or watchful waiting in early prostate cancer.

Bill-Axelson A, Holmberg L, Garmo H, Rider JR, Taari K, Busch C, Nordling S, Häggman M, Andersson SO, Spångberg A, Andrén O, Palmgren J, Steineck G, Adami HO, Johansson JE.

N Engl J Med. 2014

SPCG-4

Abstract

63

Long-term distress after radical prostatectomy versus watchful waiting in prostate cancer: a longitudinal study from the Scandinavian Prostate Cancer Group-4 randomized clinical trial.

Bill-Axelson A, Garmo H, Holmberg L, Johansson JE, Adami HO, Steineck G, Johansson E, Rider JR.

Eur Urol. 2013

SPCG-4

Abstract

62

Late radiation effects to the rectum and anus after treatment for prostate cancer: validity of the LENT/SOMA score.

Lund JÅ, Kaasa S, Wibe A, Widmark A, Fransson P.

Acta Oncol. 2013

Posaproca/SPCG

Abstract

61

Results from the Scandinavian Prostate Cancer Group Trial Number 4: A randomized controlled trial of radical prostatectomy versus watchful waiting.

Holmberg L, Bill-Axelson A, Steineck G, Garmo H, Palmgren J, Johansson E, Adami HO, Johansson JE.

J Natl Cancer Inst Monogr. 2012

SPCG-4

Abstract

60

Toxicity in patients receiving adjuvant docetaxel + hormonal treatment after radical radiotherapy for intermediate or high-risk prostate cancer: a preplanned safety report of the SPCG-13 trial

Kellokumpu-Lehtinen PL, Hjälm-Eriksson M, Thellenberg-Karlsson C, Åström L, Franzen L, Marttila T, Seke M, Taalikka M, Ginman C

Prostate Cancer Prostatic Dis. 2012

SPCG-13

Abstract

59

Individualized estimation of the benefit of radical prostatectomy from the Scandinavian Prostate Cancer Group-4 randomized trial.

Vickers A, Bennette C, Steineck G, Adami HO, Johansson JE, Bill-Axelson A, Palmgren J, Garmo H, Holmberg L.

Eur Urol. 2012

SPCG-4

Abstract

58

Long-term quality of life outcomes after radical prostatectomy or watchful waiting: the Scandinavian Prostate Cancer Group-4 randomized trial.

Johansson E, Steineck G, Holmberg L, Johansson JE, Nyberg T, Ruutu M, Bill-Axelson A; SPCG-4 investigators.

Lancet Oncol 2011

SPCG-4

Abstract

57

Side-effects of post-treatment biopsies in prostate cancer patients treated with endocrine therapy alone or combined with radical radiotherapy in the Scandinavian Prostate Cancer Group-7 randomized trial.

Solberg A, Widmark A, Tasdemir I, Ahlgren A, Angelsen A.

Scand J Urol Nephrol. 2011

SPCG-7 Biopsy study

Abstract

56

Residual prostate cancer in patients treated with endocrine therapy with or without radical radiotherapy: a side study of the SPCG-7 randomized trial

Solberg A, Haugen OA, Viset T, Bergh A, Tasdemir I, Ahlgren G, Widmark A, Angelsen A

Int J Radiat Oncol Biol Phys. 2011 May 1;80(1):55-61

SPCG-7 Biopsy study

Abstract